SENTOSA
LIVE

Serial Number

79117643

Owner

Vela Holding Pte. Ltd

Attorney

Stacy L. Emhoff

Filing Date

May 2, 2012

Add to watchlist:

No watchlists yet
View on USPTO

SENTOSA Trademark

Serial Number: 79117643 • Registration: 4390059

SENTOSA is a trademark filed by Vela Holding Pte. Ltd on May 2, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Vela Holding Pte. Ltd (4 trademarks)

#02-04/05/06 The Kendall

Entity Type: 99

Vela Diagnostics Holding Pte. Ltd. (7 trademarks)

50 SCIENCE PARK ROAD

Entity Type: 24

Trademark Details

Filing Date

May 2, 2012

Registration Date

August 27, 2013

Published for Opposition

June 11, 2013

Goods & Services

Scientific apparatus and instruments for laboratory use, in particular for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances; scientific apparatus and instruments for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances, spectrophotometers for measuring relative DNA, RNA and protein; computer hardware; computer software for operation and maintenance of scientific apparatus, instruments and equipment, namely, for electrophoretic apparatuses, homogenizers, spectrophotometers and laboratory robots; computer software for creating experimental profiles and providing experimental reports based on sample preparation, modification and manipulation of cells as well as on synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; computer software for creating reports of apparatus performance verification, namely, for apparatuses for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances, and for apparatuses for non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances, spectrophotometers for measuring relative DNA, RNA and protein; computer software for analyzing, displaying and visualizing experimental data and biological data, namely, polymerase chain reaction data, Real-Time-polymerase chain reaction data, and electrophoresis data

Pharmaceutical and veterinary preparations, namely, biological substances and chemicals used for medical scientific and medical research purposes, namely, reagents and solvents for research, in particular for sample preparation, modification and manipulation of cells as well as for the performance of synthesis, amplification, labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, marcomolecules and biologically active substances; kits consisting primarily of protein assays and chemical reagents for medical scientific and medical research purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; in-vitro diagnostic preparations for medical purposes; sanitary preparations for medical purposes

Biological and chemical substances used in industry and for scientific and research purposes, namely, diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents for research and not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, synthesis, amplification, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, marcomolecules and biologically active substances; kits consisting primarily of nucleic acid assays and chemical reagents for research, except for human medicine and veterinary medicine purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules

Medical apparatus and implements, namely, apparatus and implements for the conducting and evaluation of clinical diagnostic examinations for medical purposes

[ Scientific and technological services and research services and scientific consultancy services in the field of scientific research, analysis and testing in the field of clinical, veterinary, environmental and medical diagnosis; development of computer hardware and software for the operation and maintenance of scientific apparatus, instruments and equipment; [ development of computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification; development of computer software for analyzing, displaying and visualizing experimental data and biological data ] * all of the aforementioned services only in the field of clinical, veterinary, environmental and medical diagnosis * ]

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Apr 12, 2025 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 13, 2025 INPS
INVALIDATION PROCESSED
Mar 13, 2025 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 30, 2024 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 29, 2024 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Apr 29, 2024 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 23, 2024 APRE
TEAS SECTION 71 RECEIVED
Aug 28, 2023 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Aug 27, 2022 REM4
INTERNATIONAL REGISTRATION RENEWED
Jun 17, 2022 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Aug 27, 2021 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 16, 2021 ADCH
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 7, 2019 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
May 7, 2019 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 30, 2019 APRE
TEAS SECTION 71 & 15 RECEIVED
Apr 8, 2019 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 27, 2018 REM3
PARTIAL INVALIDATION PROCESSED BY THE IB
Feb 20, 2016 INNP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2016 NREP
CHANGE OF OWNER RECEIVED FROM IB
Feb 12, 2016 CHLD
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jan 26, 2016 INPS
INVALIDATION PROCESSED
Jan 26, 2016 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 9, 2015 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 10, 2015 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 9, 2015 NREP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Mar 10, 2015 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Mar 9, 2015 COC.
ASSIGNED TO PARALEGAL
Mar 9, 2015 PLGL
LIMITATION OF GOODS RECEIVED FROM IB
Mar 5, 2015 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 25, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 6, 2013 FICS
FINAL DISPOSITION PROCESSED
Dec 5, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 27, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 27, 2013 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jun 11, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 6, 2013 PREV
ASSIGNED TO LIE
May 3, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 3, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2013 TROA
REFUSAL PROCESSED BY IB
Oct 26, 2012 RFNT
APPLICATION FILING RECEIPT MAILED
Oct 5, 2012 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 4, 2012 RFCS
REFUSAL PROCESSED BY MPU
Oct 4, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 4, 2012 RFCR
NON-FINAL ACTION WRITTEN
Oct 3, 2012 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Oct 3, 2012 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 3, 2012 RFCR
NON-FINAL ACTION MAILED
Oct 2, 2012 CNRT
NON-FINAL ACTION WRITTEN
Oct 2, 2012 CNRT
NON-FINAL ACTION WRITTEN
Oct 2, 2012 CNRT
ASSIGNED TO EXAMINER
Oct 1, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 1, 2012 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 28, 2012 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 28, 2012 REPR